South Korea: can foreign or non-resident intended parents qualify for surrogacy?
The sources do not establish a complete statutory eligibility route for intended parents under a surrogacy-specific framework. That is not permission: medical treatment, reproductive material, payments, parentage and immigration must be assessed separately.
The short answer
There is no safe blanket answer that all foreign applicants are eligible, or that all non-residents, single people or unmarried couples are barred. In the primary legal sources, no South Korean statute sets out a complete surrogacy-specific eligibility test for intended parents based on nationality, immigration residence, marriage or relationship status. This is a limited finding about the sources, not proof that every arrangement is lawful. The decisive questions are whether the proposed medical process and use of reproductive material comply with binding rules, whether payments or intermediary activity are lawful, and how parentage and registration would be handled after birth. Do not sign or pay because an agency says your category is “approved”. Ask for a written, fact-specific Korean legal analysis before treatment or payment.
There is a decisive additional constraint: on 24 April 2025 the Supreme Court held that a surrogacy agreement requiring delivery of a child to others, and the surrogate’s agreement to relinquish maternal rights, are void under Civil Act Article 103. No nationality, residence or marital category overrides that holding.
What the binding statute does regulate
The Bioethics and Safety Act regulates embryo production, reproductive material and consent. Article 22 requires a medical institution producing embryos for in-vitro fertilisation to be designated for that purpose. Article 23 says embryos must not be produced for a purpose other than pregnancy; it restricts fertilisation using a deceased person’s egg or sperm and a minor’s egg or sperm, subject to the stated exception for a married minor seeking a child; and it prohibits providing or using embryos, eggs or sperm, or arranging that activity, in return for money, property interests or other consideration. Article 24 requires written consent from the relevant reproductive-cell donor, the person subject to IVF and, where applicable, the spouse of a donor or IVF patient, after the required explanation. The official English text identifies Act No.
The Korean official law portal displays the Bioethics and Safety Act as effective 1 October 2025 (Act No. 21065). Article 23 also bans selecting eggs and sperm for fertilisation with the aim of choosing the child’s sex. The previously consulted English rendering reflects a 2024 version, not confirmation of the current consolidated text; have counsel work from the current Korean wording.
Foreign nationality: neither automatic approval nor automatic exclusion
The sources do not identify a surrogacy-specific rule that automatically admits foreign intended parents or categorically excludes them because they are not Korean citizens. Neither conclusion should be inferred from silence. The Bioethics and Safety Act regulates medical institutions and reproductive-material procedures; it does not create a clear application process through which a foreign person can obtain official approval as an intended parent. A clinic’s willingness to discuss a case is not a statutory authorisation. Foreign applicants also need separate advice under the law of each relevant country, including the intended parents’ country of nationality or residence, because Korean treatment and the child’s legal status abroad are different questions.
Residence, visa and time in Korea
Korean law sets no surrogacy-specific minimum period of residence, Korean address requirement or minimum number of days that intended parents must spend in the country. That does not mean ordinary immigration rules or a medical institution’s intake rules disappear. Visa permission, length of stay, hospital access, identity checks, interpretation, insurance and the practical ability to remain near the birth are separate matters to confirm. Korean residence does not itself make a person a legal parent; non-residence does not, on the sources, prove automatic ineligibility. Ask the clinic to identify any residence condition it applies and whether that condition comes from legislation, administrative guidance or its own policy.
Marriage and relationship status
Article 24 of the Bioethics and Safety Act refers to the spouse, if any, of the reproductive-cell donor or the person undergoing IVF as a consent-holder. That is a specific consent rule; it is not a general rule that married intended parents qualify for surrogacy. It also does not, by itself, prove that single applicants, unmarried couples, cohabiting partners or same-sex couples are universally eligible or universally prohibited. The legal question depends on the exact medical arrangement, the people whose consent is required, clinic policy and the intended parentage route. Do not treat a clinic’s preference for a particular family model as a statutory rule unless it identifies the provision that imposes it. Treatment access, recognition of a relationship and legal parentage are distinct questions.
How common applicant situations should be assessed
- Foreign married couple: nationality and marriage alone do not establish eligibility. Obtain the clinic’s written position and independent Korean legal advice on the proposed procedure and parentage.
- Foreign person living in Korea: residence may matter for practical or immigration reasons, but it is not a surrogacy eligibility test under published law.
- Non-resident applicants: no surrogacy-specific residence threshold was identified in the sources. Confirm visa, treatment access, required identity documents and time needed in Korea.
- Single, unmarried or same-sex applicants: do not assume a universal statutory yes or no. Ask for the clinic’s current written policy and the legal basis, then assess parentage separately.
- Genetic link to the child: a genetic relationship does not, by itself, guarantee recognition as a legal parent or registration in Korea or another country.
- Agency or clinic says “you qualify”: request the exact legal provisions, the scope of the written decision and a clear statement of unresolved parentage and travel risks. Marketing is not legal clearance.
What the 2025 Supreme Court decision changes for applicants
In Supreme Court judgment 2022Meu15371 of 24 April 2025, the court held that an agreement for a woman to bear a child by assisted reproduction and hand the child to others is void as contrary to public order under Civil Act Article 103; a connected waiver of her rights as the birth mother is also void. The particular case concerned a woman who both supplied the egg and gave birth. The court treated her as the mother, notwithstanding the invalid agreement. It set aside the lower decision and remanded for examination of whether her claim to confirm parentage could exceptionally amount to abuse of process where recognising the claim would gravely harm the child’s welfare. The remand did not validate the surrogacy agreement or make the intended parents legal parents.
The decision does not establish a foreign-applicant licensing route, a general criminal prohibition of every medical act, or the exact parentage result where a gestational carrier has no genetic connection. Those questions require separate current Korean-law analysis. In practical terms, a proposed handover or parental-rights waiver cannot be treated as an enforceable safeguard; independent Korean counsel should analyse the specific participants and a lawful child-status pathway before any treatment or financial commitment.
Parentage after birth is a separate legal test
Eligibility to undergo a procedure and the identity of a child’s legal parents after birth are separate issues. A Yonhap report dated 18 May 2018 described a Seoul Family Court appellate decision involving a child born in the United States through a surrogate. The intended parents’ Korean birth-registration application had been refused because the foreign birth certificate named the surrogate as mother. According to the report, the court considered childbirth more important than genetics when determining maternity. The full judgment has not been independently, so the report must not be treated as a universal or final statement of every case. The same report also says that childbirth through a surrogate is forbidden in South Korea, but the article does not identify the statutory basis or scope of that broad statement. This guide therefore does not repeat it as a verified blanket rule; Korean counsel should check the underlying judgment and current law. The report still shows why intended parents should not assume a contract or genetic test will settle parentage. Civil Act Article 844 addresses the presumption of a husband’s paternity in specified marital circumstances; it is not a surrogacy approval procedure.
Documents to prepare for a legal review
- Passports and proof of nationality for each intended parent; current residence and visa information, if relevant.
- Civil-status records: marriage certificate, evidence of a registered or unregistered partnership if relevant, and final divorce or death certificates for any previous spouse where applicable.
- A clear medical summary and description of the proposed treatment: who will provide eggs or sperm, where the embryo will be created, and who would carry the pregnancy.
- The clinic’s legal name, designation status for embryo production, written acceptance or refusal, current patient policy and the consent forms it proposes to use.
- Every draft agreement, fee schedule, intermediary arrangement, refund clause and payment route. Identify any payment described as compensation, expenses or a service fee.
- A written parentage plan for the birth jurisdiction and each relevant home country, including registration, citizenship, travel documents and permission for the child to leave and enter each country.
A safer order of steps before paying or starting treatment
- First, instruct a Korean lawyer independent of the agency or clinic to assess the exact facts and current legislation.
- Second, obtain a written answer from the proposed medical institution. Ask which procedures it will perform, whether it is designated under Article 22, who it regards as the IVF patient, and whose written consent it requires under Article 24.
- Third, ask counsel to analyse Article 23 separately for embryo and gamete use, payment and brokerage. Do not assume the statutory prohibition on consideration for reproductive material automatically decides every question about gestational services; equally, do not assume a surrogate payment is lawful.
- Fourth, obtain a written parentage and birth-registration route before embryo transfer, with a plan for a refusal or disagreement.
- Fifth, obtain advice from the intended parents’ nationality/residence countries and relevant consulates about parentage recognition, citizenship, passport issuance and travel.
- Because of the 2025 Supreme Court ruling, do not sign a child-handover/parental-rights-waiver agreement or make a payment in reliance on its enforceability. Obtain independent Korean advice on the exact structure, possible lawful alternatives, financial exposure and the child’s legal status first.
If the clinic says yes, or refuses the case
Ask the clinic to distinguish binding law from internal eligibility criteria. Request the policy’s date and version, the exact statutory provision relied on, whether the answer is conditional, and whether it covers only medical treatment or also parentage and birth registration. Ask how spouse consent will be handled, how reproductive material will be sourced, what payments are proposed, and what happens if treatment fails, a pregnancy ends, the parties separate or the surrogate and intended parents disagree. A refusal by one clinic is not proof that a statute bans every arrangement. Acceptance by one clinic is not proof that the whole arrangement is lawful or that the intended parents will be registered as parents. Do not conceal marital status, nationality, prior treatment or other facts to pass screening.
Keep three legal questions separate
Before making a decision, require a separate answer to each question: (1) may the proposed medical and reproductive-material steps lawfully be carried out by the specific people and institution; (2) what legal parentage will be recognised after birth, and by which authority; and (3) can the child obtain the necessary nationality, passport or travel document and lawfully leave Korea and enter the intended parents’ country? A positive answer to one does not decide the others. A contract, a clinic’s intake email, genetic evidence or a foreign birth certificate may be relevant evidence, but none should be treated as a universal substitute for the applicable legal process.
What a useful written legal opinion should contain
The opinion should name the people and jurisdictions, describe the exact proposed medical steps, cite the current statutory text and any applicable case law, distinguish legislation from clinic policy, explain the limits of any consent or contract, analyse payment and intermediary risks, and set out a realistic parentage and registration plan with fallback options. It should also identify any issue that cannot be confirmed from accessible primary sources. The 2018 judgment is available here only through a news report, clinic policies have not been independently verified, and a Korean specialist should recheck the consolidated law and applicable practice before anyone relies on the conclusions.
Sources and limits
The links below are the sources actually. The Yonhap item is a news report, not the full court judgment.
- S1. Bioethics and Safety Act (Republic of Korea)
- S2. Civil Act (Republic of Korea)
- S3. Court recognizes surrogate mother as legal parent — Yonhap News Agency
- S4. Supreme Court Decision 2022Meu15371 (24 April 2025), full Korean judgment
- S5. Bioethics and Safety Act, Article 23, Korean version effective 1 October 2025
- S6. Civil Act, Article 103, Korean version effective 17 March 2026
